PROCEEDINGS VOLUME 2133
OE/LASE '94 | 23-29 JANUARY 1994
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy III
IN THIS VOLUME

0 Sessions, 31 Papers, 0 Presentations
Clinical  (7)
Pre-clinical  (7)
Mechanisms  (9)
OE/LASE '94
23-29 January 1994
Los Angeles, CA, United States
Clinical
Proc. SPIE 2133, Endobronchial photodynamic therapy for hemoptysis, 0000 (19 July 1994); doi: 10.1117/12.179966
Proc. SPIE 2133, Results of the phase II study of photodynamic therapy in Japan, 0000 (19 July 1994); doi: 10.1117/12.179974
Proc. SPIE 2133, In vitro cellular effects of <delta>-aminolevulinic acid sensitized photodynamic therapy, 0000 (19 July 1994); doi: 10.1117/12.179989
Proc. SPIE 2133, Balloon photodynamic therapy of esophageal cancer: effect of increasing balloon size, 0000 (19 July 1994); doi: 10.1117/12.179994
Proc. SPIE 2133, Phototherapy of Barrett's esophagus, 0000 (19 July 1994); doi: 10.1117/12.179995
Proc. SPIE 2133, Photodynamic therapy and the treatment of neoplastic diseases of the head and neck: an update, 0000 (19 July 1994); doi: 10.1117/12.179996
Pre-clinical
Proc. SPIE 2133, Delta-aminolevulinic acid as a photosensitizer precursor for the treatment of hepatoma cells in vitro, 0000 (19 July 1994); doi: 10.1117/12.179967
Proc. SPIE 2133, Photodynamic efficiency of aminolevulinic acid after two different incubation times in two cell lines, 0000 (19 July 1994); doi: 10.1117/12.179968
Proc. SPIE 2133, Photosensitization with benzochlorin iminium salts, 0000 (19 July 1994); doi: 10.1117/12.179969
Proc. SPIE 2133, Photodynamic therapy of endometriosis with HpD (Photosan III) in a new in vitro model, 0000 (19 July 1994); doi: 10.1117/12.179970
Proc. SPIE 2133, Comparison of Ti:sapphire laser and excimer-laser-pumped dye laser for PDT with Zn(II)-phthalocyanine, 0000 (19 July 1994); doi: 10.1117/12.179971
Proc. SPIE 2133, Preliminary comparison of the photosensitizing properties in vitro of protoporphyrindisodiumsalt in aqueous solution and liposomes, 0000 (19 July 1994); doi: 10.1117/12.179972
Proc. SPIE 2133, Meso-tetra(hydroxyphenyl)chlorin: an in vivo photodegradation study, 0000 (19 July 1994); doi: 10.1117/12.179973
Detection/Dosimetry
Proc. SPIE 2133, Exploitation of interstitial brachytherapy techniques for photodynamic therapy--II. Novel photosensitizeers for the treatment of solid tumors, 0000 (19 July 1994); doi: 10.1117/12.179975
Proc. SPIE 2133, Exploitation of interstitial brachytherapy techniques for photodynamic therapy--I. Treatment planning for interstitial photoexcitation therapy: a photodosimetry treatment planning system, 0000 (19 July 1994); doi: 10.1117/12.179976
Proc. SPIE 2133, Light dosimetry in photodynamic therapy using optical fiber delivery, 0000 (19 July 1994); doi: 10.1117/12.179977
Proc. SPIE 2133, Light delivery and dosimetry for photodynamic therapy in an ovarian-cancer mouse model, 0000 (19 July 1994); doi: 10.1117/12.179978
Proc. SPIE 2133, Laser-induced fluorescence spectroscopy at endoscopy, 0000 (19 July 1994); doi: 10.1117/12.179979
Proc. SPIE 2133, Point fluorescence measurements of transformed tissues using 2-[1-hexyloxyethel]-2-devinyl pyropheophorbide-a, 0000 (19 July 1994); doi: 10.1117/12.179980
Proc. SPIE 2133, Red diode laser for photodynamic therapy: a small animal efficacy study, 0000 (19 July 1994); doi: 10.1117/12.179981
Proc. SPIE 2133, Fluorescence spectroscopy for diagnosis of esophageal cancer, 0000 (19 July 1994); doi: 10.1117/12.179982
Mechanisms
Proc. SPIE 2133, Microelectrode measurements of photochemical oxygen depletion in multicell tumor spheroids during photodynamic therapy, 0000 (19 July 1994); doi: 10.1117/12.179983
Proc. SPIE 2133, Photofrin and 5-aminolevulinic acid permeation through oral mucosa in vitro, 0000 (19 July 1994); doi: 10.1117/12.179984
Proc. SPIE 2133, Studies of the significance of functional and structural changes in mitochondria in PhotofrinTM-photodynamic-therapy-resistant cells, 0000 (19 July 1994); doi: 10.1117/12.179985
Proc. SPIE 2133, Theoretical study of the influence of sensitizer photobleaching on depth of necrosis in photodynamic therapy, 0000 (19 July 1994); doi: 10.1117/12.179986
Proc. SPIE 2133, Laser blood flowmetry in malignant tumors during photodynamic therapy: an experimental study, 0000 (19 July 1994); doi: 10.1117/12.179987
Proc. SPIE 2133, Studies on porphyrin photoproducts in solution, cells, and tumor tissue, 0000 (19 July 1994); doi: 10.1117/12.179988
Proc. SPIE 2133, Microscopic studies on aminolevulinic-acid-incubated tumor cells and tumor spheroids, 0000 (19 July 1994); doi: 10.1117/12.179990
Proc. SPIE 2133, Morphological changes of tumor microvasculature following photodynamic therapy, 0000 (19 July 1994); doi: 10.1117/12.179991
Proc. SPIE 2133, Direct phosphorescent detection of primary event of photodynamic action, 0000 (19 July 1994); doi: 10.1117/12.179992
Clinical
Proc. SPIE 2133, Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas, 0000 (19 July 1994); doi: 10.1117/12.179993
Back to Top